Company Profile
|
Opthea Ltd
(NASDAQ: OPT)
|
5:30 PM UTC, 07/03/24 | |||
|---|---|---|---|---|
| Last: $1.89 | Change: -0.02 | %Change: -0.84% | Volume: 11,571 | |
Detailed Quote
M = Million B = Billion
Price Performance
Management Effectiveness
Profitability
| Open: | $ 1.88 | Volume: | 11,571 | |
|---|---|---|---|---|
| High: | $ 1.91 | Yield(%) | 0.00 | |
| Low: | $ 1.85 | P/E Ratio (ttm): | n/a | |
| Dividend ($): | n/a | Market Cap ($): | 287.95M | |
| EPS ($) | n/a | Shares Out: | 150.76M |
| % Price Change (last 4 weeks): | -24.37 |
|---|---|
| % Price Change (last 13 weeks): | -51.75 |
| % Price Change (last 26 weeks): | -36.25 |
| % Price Change (last 52 weeks): | -32.65 |
| % Price Change (year to date): | -35.25 |
| Return on Equity (%): | -673.68 |
|---|---|
| Return on Assets (%): | -178.83 |
| Return on Invested Capital (%): | -214.29 |
| Gross Profit Margin (%): | n/a |
|---|---|
| Net Profit Margin (%): | -131469.74 |
| Operating Profit Margin (%): | -138647.92 |
Price & Volume
Company Information
Per Share Data
Valuation Ratios
Financial Strength
|
|
|
| 50-day Moving Average: | $2.82 |
|---|---|
| 200-day Moving Average: | $2.67 |
| Avg. Daily Vol. (last 50 days): | 27,092 |
| Avg. Daily Vol. (last 200 days): | 23,980 |
| 52-wk high: | $4.40 |
| 52-wk low: | $1.60 |
| Bid: | $1.88 |
| Ask: | $1.93 |
|
Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development of biological therapeutics for the treatment of progressive retinal diseases. It focuses on treating neovascular age-related macular degeneration and diabetic macular edema, which causes visual impairment among elderly and diabetic patients. The company was founded on October 17, 1984, and is headquartered in South Yarra, Australia.
|
|
Opthea Ltd
650 Chapel Street Suite 0403 Level 4 South Yarra VI 3141 Phone: 61.3.9826.0399 Fax: 61.3.9824.0083 http://www.opthea.com |
| Earnings (1year) ($): | -2.17 |
|---|---|
| Annual Dividend ($): | 0.00 |
| Current P/E Ratio (ttm): | n/a |
| Book Value ($): | -0.09 |
| Cash Flow ($): | -2.11 |
| Price/Earnings (x): | n/a |
|---|---|
| Price/Sales (x): | 1653.27 |
| Price/Book (x): | n/a |
| Price/Cash Flow (x): | n/a |
| Quick Ratio (x): | 5.25 |
|---|---|
| Current Ratio (x): | 5.25 |
| LT Debt/Equity (x): | n/a |
| Total Debt/Equity (x): | n/a |
